Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma von Dytfeld, Dominik, Jasielec, Jagoda, Griffith, Kent A, Lebovic, Daniel, Vesole, David H, Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E, McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi, Jakubowiak, Andrzej J

Volltext

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma von Jakubowiak, Andrzej J., Dytfeld, Dominik, Griffith, Kent A., Lebovic, Daniel, Vesole, David H., Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Nordgren, Brian, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E., McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi

Volltext

A Phase II Study of Consolidation Treatment with Iodione-131 Tositumomab (Bexxar™) in Multiple Myeloma (MM) von Lebovic, Daniel, Kaminski, Mark S., Anderson, Tara B., Detweiler-Short, Kristen, Griffith, Kent A., Jobkar, Terri L., Kandarpa, Malathi, Jakubowiak, Andrzej

Volltext

Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up von Jakubowiak, Andrzej J., Dytfeld, Dominik, Griffith, Kent A., Jasielec, Jagoda, McDonnell, Kathryn, Lebovic, Daniel, Vesole, David H, Jagannath, Sundar, Chottiner, Elaine G., Anderson, Tara B., Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra Z., Jobkar, Terri L., Durecki, Diane E., Mietzel, Melissa A, Couriel, Daniel R., Vij, Ravi, Kaminski, Mark Stefan

Volltext

Stringent complete response (sCR) in patients (pts) with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX) von Jakubowiak, Andrzej J., Griffith, Kent A., Dytfeld, Dominik, Vesole, David H., Jagannath, Sundar, Anderson, Tara B., Nordgren, Brian K., Detweiler-Short, Kristen, Lebovic, Daniel, Stockerl-Goldstein, Keith, Jobkar, Terri L., Wear, Sandra Marija, Al-Zoubi, Ammar, Ahmed, Asra Z., Mietzel, Melissa A, Couriel, Daniel R., Kaminski, Mark Stefan, Hussein, Mohamad A., Yeganegi, Homa, Vij, Ravi

Volltext

Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM) von Jakubowiak, Andrzej J, Dytfeld, Dominik, Jagannath, Sundar, Vesole, David H., Anderson, Tara B., Nordgren, Brian K., Detweiler-Short, Kristen, Lebovic, Daniel, Stockerl-Goldstein, Keith E., Griffith, Kent A., Jobkar, Terri L., Durecki, Diane E, Wear, Sandra M., Ott, Robert F, Al-Zoubi, Ammar, Mietzel, Melissa A, Hussein, M, Couriel, Daniel, Leveque, Joseph A, Vij, Ravi

Volltext